FIT (Vertebral Fracture Arm)
1996
Fracture Intervention Trial — Vertebral Fracture Arm
In 2,027 postmenopausal women with ≥1 prevalent vertebral fracture, alendronate reduced new vertebral, clinical and hip fractures compared with placebo.
Result
Efficacy: New morphometric vertebral fractureRR 0.53
Below 1 favours alendronate, above 1 favours placebo.
Also reported: Clinical vertebral RR 0.45; hip fracture RR 0.49 (p=0.047).
- Subtopic
- Bisphosphonates
- Design
- Double-blind RCT, 36 mo
- Relevance
- Practice-defining: a trial the field needs to know.
- Source
- Black DM, et al. Lancet. 1996;348(9041):1535-1541.doi 10.1016/S0140-6736(96)07088-2
Discussion & critique
Established bisphosphonates as first-line antifracture therapy, still the foundation of modern osteoporosis treatment.